| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Lymphoma | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Mycoses | |||||
| Mycosis Fungoides | |||||
| Sezary Syndrome | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Disease | |||||
| Immune System Diseases | |||||
| Immunoproliferative Disorders | |||||
| Lymphatic Diseases | |||||
| Lymphoma, Non-Hodgkin | |||||
| Lymphoma, T-Cell | |||||
| Lymphoma, T-Cell, Cutaneous | |||||
| Lymphoproliferative Disorders | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Pathologic Processes | |||||
| 4 | Interventions listed in this trial | ||||
| aldesleukin | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Interleukin-2 | |||||
| 6 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Non-Narcotic | |||||
| Anti-HIV Agents | |||||
| Anti-Infective Agents | |||||
| Anti-Retroviral Agents | |||||
| Antineoplastic Agents | |||||
| Antiviral Agents | |||||
| Central Nervous System Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Robert H. Lurie Cancer Center | |||||
| National Cancer Institute (NCI) | |||||
|
